Elelyso (taliglucerase alfa)
Orphan
- Region
- 🇪🇺 EU
- Active substance
- taliglucerase alfa
- Company
- Pfizer Ltd.
- Status
- Refused
- Therapeutic area
- Gaucher Disease
- CHMP opinion
- Tue 03 Jul 2012
- Designations
- Orphan
- Application
- EMEA/H/C/002250
- ATC
- A16AB11
- Official record
- www.ema.europa.eu
Indication
treatment of Gaucher disease
Regulatory milestones
No milestones recorded in the last year.
Follow Elelyso
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.